Emma R. Sutton
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
2nd NMD4C basic research summer school on promoting standardized protocols to advance translational research in neuromuscular disorders.
Journal: Journal of neuromuscular diseases
Published: December 19, 2025
Mifepristone alone and in combination with scAAV9-SMN1 gene therapy improves disease phenotypes in Smn2B/- spinal muscular atrophy mice.
Journal: Scientific reports
Published: March 31, 2025
Peripheral defects precede neuromuscular pathology in the Smn2B/- mouse model of spinal muscular atrophy.
Journal: Journal of neuromuscular diseases
Published: February 20, 2025
Modulation of miR-145 in a mouse model of multiple sclerosis: A promising approach to attenuate inflammation and degeneration.
Journal: Neurobiology of disease
Published: February 18, 2025
Exercise, disease state and sex influence the beneficial effects of Fn14-depletion on survival and muscle pathology in the SOD1G93A amyotrophic lateral sclerosis (ALS) mouse model.
Journal: Skeletal muscle
Published: July 05, 2024
Liver SMN restoration rescues the Smn2B/- mouse model of spinal muscular atrophy.
Journal: EBioMedicine
Published: May 14, 2024
A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models.
Journal: Human molecular genetics
Published: July 13, 2023
Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophy.
Journal: Nature biomedical engineering
Published: January 21, 2023
Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice.
Journal: Skeletal muscle
Published: September 13, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026